Vaccines & Immunity Archives - Page 2 of 35

Summary:
As of April 8, 2020, CEPI reports 115 vaccine candidates are in varying stages of development, 78 of which are confirmed as active and 37 are unconfirmed. To end the COVID-19 Pandemic safe and effective vaccines will be required for the entire global population. Estimated requirement: 5 billion doses.
Published for educational purposes and social benefit, not for profit. Not a recommendation or endorsement. Always consult your doctor for medical advice.

July 2021

GOV UK | SAGE | How long will vaccines continue to protect against COVID?

sibiu1182021-08-07T07:03:14+00:00July 30th, 2021|

Reviewed by SAGE. meetings, July 2021 Executive summary 1. It is highly likely that vaccine induced immunity to SARS-CoV-2 infection, and potentially severe disease (but probably to a lesser extent) [...]

GOV UK | SAGE (Scientific Advisory Group for Emergencies) | International vaccination: Potential impact on viral evolution and UK public health

sibiu1182021-08-07T06:22:08+00:00July 30th, 2021|

International vaccination: Potential impact on viral evolution and UK public health Contributors (in alphabetical order): Samuel Clifford, Rosalind Eggo, Julia Gog, Bryan Grenfell, Deirdre Hollingsworth, Petra Klepac, Jessica Metcalf, Billy [...]

CURATED LIST: Outspoken Anti-vaxxers DEAD of COVID-19

sibiu1182021-08-22T08:36:22+00:00July 30th, 2021|

Popular voices who may have led to the deaths of countless followers. Don't make the same deadly mistake. Get vaccinated! Herman Cain - US Politician (DEAD at 74) Pressley Stutts [...]

GOV UK | SAGE (Scientific Advisory Group for Emergencies) | Long term evolution of SARS-CoV-2, 26 July 2021 | Can we predict the limits of SARS-CoV-2 variants and their phenotypic consequences?

sibiu1182021-08-07T07:04:47+00:00July 30th, 2021|

SAGE Research and analysis Long term evolution of SARS-CoV-2, 26 July 2021 Paper prepared by academics on the viral evolution of COVID-19. Can we predict the limits of SARS-CoV-2 variants [...]

GOV UK | News story COVID-19 vaccine surveillance report published | Infections prevented by COVID-19 vaccines doubles to 22 million and deaths prevented rises to 60,000

sibiu1182021-07-29T14:58:26+00:00July 29th, 2021|

Infections prevented by COVID-19 vaccines doubles to 22 million and deaths prevented rises to 60,000 Public Health England (PHE) has published its latest weekly COVID-19 vaccine surveillance report. Latest PHE estimates that [...]

CNBC | Pfizer sells $7.8 billion in Covid shots in the second quarter, raises 2021 guidance on vaccine sales

sibiu1182021-07-31T06:26:05+00:00July 29th, 2021|

Key Points Pfizer said it sold $7.8 billion in Covid-19 shots in the second quarter. It also raised its 2021 sales forecast for the vaccine to $33.5 billion from $26 [...]

NATURE | Published 12 January 2018 | mRNA vaccines — a new era in vaccinology

sibiu1182021-07-27T08:46:34+00:00July 27th, 2021|

mRNA was discovered in 1961. mRNA vaccine science and technology has been in development for 60 years... Key Points: Recent improvements in mRNA vaccines act to increase protein translation, modulate [...]

BBC NEWS | Covid: Is UK now a breeding ground for new variants?

sibiu1182021-07-27T05:34:31+00:00July 27th, 2021|

Are we in the danger zone for creating new variants that could weaken the ability of vaccines to shield us from Covid? And does it matter? Scientists have warned that [...]

Journal of Translational Medicine | Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants

sibiu1182021-07-24T09:18:36+00:00July 24th, 2021|

Abstract Background Tracking the genetic variability of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is a crucial challenge. Mainly to identify target sequences in order to generate robust vaccines and [...]

GISAID | Official hCoV-19 Reference Sequence

sibiu1182021-07-23T09:43:06+00:00July 23rd, 2021|

Source: https://www.gisaid.org/references/hcov-19-reference-sequence/ hCoV-19/Wuhan/WIV04/2019 (WIV04) is the official reference sequence employed by GISAID (EPI_ISL_402124). WIV04 was chosen because of its high-quality genome sequence and because it represented the consensus of a handful of [...]